Zenlabs Holdings

Zenlabs Holdings

Early Stage

Premium Hemp & Cannabis Clones

Premium Hemp & Cannabis Clones

Overview

Raised this Round: Raised: $3,234,299

Total Commitments ($USD)

Platform

Dalmore Group

Start Date

09/09/2021

Close Date

Not Provided

Min. Goal
$1,200
Max. Goal
$17,500,001
Min. Investment

$1,200

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$1.20

Pre-Money Valuation

$27,739,820

Year Founded

2019

Industry

Alcohol, Tobacco, & Recreational Drugs

Tech Sector

AgriTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Location

San Diego, California

Business Type

Growth

Zenlabs Holdings is raising funds on Dalmore Group through Reg A+ crowdfunding. The company is involved in the cultivation, production, and selling of high-quality cannabis. The business uses sophisticated pathogen indexing, high-quality tissue cultures, and proprietary propagation methodologies to produce excellent cannabis. Zenlabs operates its farms in San Diego County and delivers exceptional THC and CBD clones. Michael Boshart founded Zenlabs in 2019. The current crowdfunding campaign has no minimum target and a maximum target of $17,500,001. The campaign proceeds will be used for greenhouse construction, greenhouse operations, and working capital.

Balance Sheet

Cash and Cash Equivalents

$1,453,424

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$5,733

Loans

$0

Property, Plant and Equipment (PP&E)

$2,342,172

Property and Equipment

$0

Total Assets

$5,996,999

Accounts Payable & Accrued Liabilities

$408,864

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$44,587

Total Liabilities

$3,072,912

Total Stockholders' Equity

$2,924,087

Total Liabilities and Equity

$5,996,999

Statement of Comprehensive Income Information

Total Revenues

$291,016

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$-274,475

Total Interest Expenses

$0

Depreciation and Amortization

$-150,352

Net Income

$-1,010,025

Earnings Per Share - Basic

$-0.05

Earnings Per Share - Diluted

$-0.05

Auditor: Dale Matheson Carr-Hilton Labonte LLP
Financials as of: 09/09/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Zenlabs Holdings on Dalmore Group 2021
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $27,739,820
Price per Share: $1.20

Follow company

Follow Zenlabs Holdings on Dalmore Group 2021

Buy Zenlabs Holdings's Deal Report

Warning: according to the close date for this deal, Zenlabs Holdings may no longer be accepting investments.

Zenlabs Holdings Deal Report

Get KingsCrowd’s comprehensive report on Zenlabs Holdings including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Zenlabs Holdings is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Zenlabs Holdings deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge